Expanding Family Health History to Include Family Medication History

The collection of family health history (FHH) is an essential component of clinical practice and an important piece of data for patient risk assessment. However, family history data have generally been limited to diseases and have not included medication history. Family history was a key component of early pharmacogenetic research, confirming the role of genes in drug response. With the substantial number of known pharmacogenes, many affecting response to commonly prescribed medications, and the availability of clinical pharmacogenetic (PGx) tests and guidelines for interpretation, the collection of family medication history can inform testing decisions. This paper explores the roots of family-based pharmacogenetic studies to confirm the role of genes in these complex phenotypes and the benefits and challenges of collecting family medication history as part of family health history intake.

Automated summary

The collection of family health history is important for clinical practice and patient risk assessment. However, family history data often exclude medication history. Early pharmacogenetic research confirmed the role of genes in drug response and with the availability of clinical pharmacogenetic tests, collecting family medication history can inform testing decisions. This paper explores the roots of family-based pharmacogenetic studies, emphasizing the benefits and challenges of collecting family medication history.